SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-17-008910
Filing Date
2017-05-12
Accepted
2017-05-12 15:26:36
Documents
5
Period of Report
2017-06-15
Effectiveness Date
2017-05-12

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A dffn20170510_def14a.htm DEF 14A 1257415
2 proxy2.jpg GRAPHIC 136192
3 proxy1b.jpg GRAPHIC 146594
4 proxy1a.jpg GRAPHIC 183196
5 dffn20170427_pre14aimg001.jpg GRAPHIC 10370
  Complete submission text file 0001437749-17-008910.txt   1915241
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37942 | Film No.: 17838228
SIC: 2834 Pharmaceutical Preparations